Although the mortality rate of female breast cancer patients in China is lower than that of lung cancer, colorectal cancer, and gastric cancer, more than 100,000 patients die from breast cancer each year; the number of patients who died from breast cancer in China accounted for 9.6% of the global total in 2008, which still shows an increasing trend [ 6 ], so it is extremely important to enhance the secondary prevention of breast cancer before achieving fundamental breakthroughs in the treatment.
← all excerpts
Diagnostic Value of Dynamic Enhanced Magnetic Resonance Imaging Combined with Serum CA15-3, CYFRA21-1, and TFF1 for Breast Cancer.
1
—
—